A clinical-stage biotechnology company focused on developing metabolic-based therapies for cancer and other serious diseases. The firm has centered its research on drug candidates designed to disrupt tumor cell metabolism, with programs that have historically included the SM-88 (racemetyrosine) plat...
No congressional trades have been disclosed for Tyme Brands Incorporated (TYMI) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.